Results 261 to 270 of about 481,968 (300)
Some of the next articles are maybe not open access.
Current Treatment Options in Gastroenterology, 2001
Infection with hepatitis C virus (HCV) accounts for 40% of cases of chronic liver disease in the United States and is now the most common indication for liver transplantation. Estimates suggest that 4 million people (1.8%) of the American population are or have been infected with HCV.
Tram T., Tran, Paul, Martin
openaire +2 more sources
Infection with hepatitis C virus (HCV) accounts for 40% of cases of chronic liver disease in the United States and is now the most common indication for liver transplantation. Estimates suggest that 4 million people (1.8%) of the American population are or have been infected with HCV.
Tram T., Tran, Paul, Martin
openaire +2 more sources
Comprehensive Therapy, 2003
Strategies for the diagnosis and treatment of chronic hepatitis C continue to evolve. Liver biopsy is now used selectively rather than routinely, and the combination peginterferon plus ribavirin is the treatment of choice for the majority of patients.
Aijaz, Ahmed, Emmet B, Keeffe
openaire +2 more sources
Strategies for the diagnosis and treatment of chronic hepatitis C continue to evolve. Liver biopsy is now used selectively rather than routinely, and the combination peginterferon plus ribavirin is the treatment of choice for the majority of patients.
Aijaz, Ahmed, Emmet B, Keeffe
openaire +2 more sources
2016
Infection with hepatitis C virus (HCV) accounts for 40% of cases of chronic liver disease in the United States and is now the most common indication for liver transplantation. Estimates suggest that 4 million people (1.8%) of the American population are or have been infected with HCV.
Athwal, Varinder, Prince, Martin
openaire +4 more sources
Infection with hepatitis C virus (HCV) accounts for 40% of cases of chronic liver disease in the United States and is now the most common indication for liver transplantation. Estimates suggest that 4 million people (1.8%) of the American population are or have been infected with HCV.
Athwal, Varinder, Prince, Martin
openaire +4 more sources
Disease-a-month : DM, 1994
Formerly the diagnosis of acute and chronic non-A, non-B hepatitis was made by the exclusion of other causes. However, in 1989 cloning of an antigenic component of the hepatitis C virus (HCV) was reported. This led to first- and second-generation tests for antibody to HCV (anti-HCV) in serum.
+5 more sources
Formerly the diagnosis of acute and chronic non-A, non-B hepatitis was made by the exclusion of other causes. However, in 1989 cloning of an antigenic component of the hepatitis C virus (HCV) was reported. This led to first- and second-generation tests for antibody to HCV (anti-HCV) in serum.
+5 more sources
Southern Medical Journal, 1997
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +2 more sources
Infection with the hepatitis C virus (HCV) is a leading cause of chronic liver disease worldwide. Epidemiologic and natural history studies have helped to define the clinical impact of HCV infection, and molecular diagnostic assays have established clinical endpoints against which therapeutic regimens are currently tested.
openaire +2 more sources
2021
Chronic hepatitis C (C-HCV) is caused by an RNA virus, genotype 1a being the most common in the United States. The infection is transmitted by parenteral exposure to contaminated blood products, body fluids, and supplies used in procedures. It becomes chronic in 80% of the patients.
openaire +1 more source
Chronic hepatitis C (C-HCV) is caused by an RNA virus, genotype 1a being the most common in the United States. The infection is transmitted by parenteral exposure to contaminated blood products, body fluids, and supplies used in procedures. It becomes chronic in 80% of the patients.
openaire +1 more source
Chronic hepatic prophyria type C
Klinische Wochenschrift, 1971In four patients with liver disease (fatty liver, fibrosis, and cirrhosis) the concentrations of uroporphyrin and heptacarboxylic porphyrin in the liver were found to be considerably elevated (up to 90 µg/g). The patients also excreted increased amounts of porphyrin with the urine (0.5–1 mg/l), although cutaneous symptoms were not present.
M, Doss +11 more
openaire +2 more sources
THERAPY FOR CHRONIC HEPATITIS C
Gastroenterology Clinics of North America, 1994Hepatitis C is the silent epidemic of the 1970s and 1980s. Interferon alfa is currently the only effective treatment. Enthusiasm for interferon therapy must be tempered because advanced disease usually requires years or even decades to develop and does not occur in all patients.
G L, Davis, J Y, Lau, H L, Lim
openaire +2 more sources